CAD 0.43
(6.25%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 142.32 Thousand CAD | -18.91% |
2022 | 175.51 Thousand USD | -32.69% |
2021 | 260.77 Thousand CAD | -16.82% |
2020 | 313.51 Thousand CAD | 54.69% |
2019 | 202.67 Thousand CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 128.81 Thousand USD | -9.5% |
2024 Q2 | 116.96 Thousand USD | -100.0% |
2023 Q4 | 142.32 Thousand USD | -6.02% |
2023 Q1 | 164.16 Thousand USD | -6.47% |
2023 Q3 | 151.44 Thousand USD | -8.35% |
2023 FY | 142.32 Thousand CAD | -18.91% |
2023 Q2 | 165.24 Thousand USD | 0.66% |
2022 Q2 | 166.59 Thousand CAD | -23.53% |
2022 FY | 175.51 Thousand USD | -32.69% |
2022 Q1 | 217.85 Thousand CAD | -16.46% |
2022 Q3 | 106.85 Thousand CAD | -35.86% |
2022 Q4 | 175.51 Thousand USD | 64.25% |
2021 Q1 | 272.49 Thousand CAD | -13.09% |
2021 FY | 260.77 Thousand CAD | -16.82% |
2021 Q4 | 260.77 Thousand CAD | -11.49% |
2021 Q3 | 294.64 Thousand CAD | -13.78% |
2021 Q2 | 341.75 Thousand CAD | 25.42% |
2020 Q2 | 364.97 Thousand CAD | 124.97% |
2020 FY | 313.51 Thousand CAD | 54.69% |
2020 Q4 | 313.51 Thousand CAD | -16.34% |
2020 Q3 | 374.73 Thousand CAD | 2.67% |
2020 Q1 | 162.23 Thousand CAD | -19.95% |
2019 FY | 202.67 Thousand CAD | 0.0% |
2019 Q4 | 202.67 Thousand CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Therma Bright Inc. | 25.39 Thousand CAD | -460.527% |
Theralase Technologies Inc. | 293.86 Thousand CAD | 51.567% |
VentriPoint Diagnostics Ltd. | 296.98 Thousand CAD | 52.076% |